By Aphios Corp.
Aphios is seeking strategic partners, collaborators, and investors to advance Zindol® and our broader oncology and supportive-care portfolio toward clinical development, regulatory approval, and commercialization. We welcome opportunities for co-development, licensing, regional partnerships, strategic investment, and technology collaborations that can accelerate the development of differentiated therapies for cancer patients and improve supportive care during treatment.
